Nuveen LLC Takes $6.01 Million Position in Ardent Health, Inc. $ARDT

Key Points

• Nuveen LLC has purchased 437,063 shares of Ardent Health, Inc. for approximately $6,010,000, representing a 0.31% ownership stake as reported in their recent SEC filing.
• Several institutional investors, including Vanguard Group Inc. and Deutsche Bank AG, significantly increased their stakes in Ardent Health in the first quarter, indicating strong investor interest.
• Equities analysts show mixed opinions on Ardent Health, with one firm setting a price target of $21.00 while another downgraded it to $14.60, leading to a general rating of "Moderate Buy" with an average target price of $19.56.

Nuveen LLC bought a new position in Ardent Health, Inc. (NYSE:ARDT - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 437,063 shares of the company's stock, valued at approximately $6,010,000. Nuveen LLC owned about 0.31% of Ardent Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the company. Point72 Asset Management L.P. boosted its position in Ardent Health by 7.9% in the fourth quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company's stock worth $27,494,000 after purchasing an additional 117,421 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of Ardent Health by 368.9% during the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock valued at $18,296,000 after buying an additional 1,046,845 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Ardent Health by 4.8% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 817,182 shares of the company's stock valued at $10,599,000 after buying an additional 37,581 shares in the last quarter. Nuveen Asset Management LLC lifted its position in shares of Ardent Health by 220.6% during the 4th quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company's stock valued at $2,895,000 after buying an additional 116,610 shares in the last quarter. Finally, Bank of America Corp DE lifted its position in shares of Ardent Health by 128.8% during the 4th quarter. Bank of America Corp DE now owns 168,370 shares of the company's stock valued at $2,876,000 after buying an additional 94,772 shares in the last quarter.

Analysts Set New Price Targets

ARDT has been the topic of a number of analyst reports. Bank of America cut Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the company from $15.50 to $14.60 in a research report on Wednesday, July 16th. Guggenheim lifted their price objective on Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, May 9th. Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. KeyCorp lowered their price objective on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Finally, Stephens reissued an "overweight" rating and set a $21.00 target price on shares of Ardent Health in a research note on Tuesday, May 20th. Eight analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $19.56.

Ardent Health Price Performance

NYSE:ARDT traded down $0.16 during trading hours on Thursday, reaching $12.55. The stock had a trading volume of 149,462 shares, compared to its average volume of 410,697. The stock has a market capitalization of $1.80 billion and a PE ratio of 7.02. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. The company has a 50 day moving average price of $12.38 and a two-hundred day moving average price of $13.26. Ardent Health, Inc. has a 52 week low of $10.10 and a 52 week high of $20.72.

Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, sell-side analysts anticipate that Ardent Health, Inc. will post 1.23 earnings per share for the current fiscal year.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.